• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artificial Intelligence

    10/9/24 8:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email

    Symposium for healthcare professionals assembles international experts to discuss digital health and AI applications to transform the practice of healthcare

    VSee Health, Inc. (NASDAQ:VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announced today that co-CEO Milton Chen, PhD, will be a keynote speaker at iA-Med 2024, a groundbreaking symposium dedicated to exploring the latest advancements in artificial intelligence (AI) for healthcare professionals

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241009397315/en/

    (Graphic: Business Wire)

    (Graphic: Business Wire)

    Presented by ProntoMedic, an early-stage incubator, the event will take place at Auditorio FEPADE in San Salvador on October 16, 2024. Attendees include a diverse audience of physicians, nurses, administrative health professionals, students and representatives from hospitals, pharmaceutical companies and laboratories.

    iA-MED 2024 is sponsored by Banco Agrícola, Applaudo Studios and VSee Health, and aims to promote innovation, collaboration and decision-making by healthcare professionals in the age of AI. Held under the theme of integrating AI into modern healthcare, the symposium will address key topics including predictive diagnostics, personalized treatments and the future of AI-driven healthcare solutions.

    Event Highlights:

    Keynote Speakers

    • Milton Chen, PhD, founder of VSee Health. Dr. Chen is a leading voice in telemedicine technology, impacting underserved communities globally through humanitarian efforts and high-profile collaborations with organizations including NASA and McKesson.
    • Jesús Seáñez, PhD, co-founder of Hera Diagnostics, a pioneer in using optoelectronics and AI for early cancer detection. With over a decade of experience, Dr. Seáñez's innovative devices, such as InstaPAP® and HeraFem®, are revolutionizing cancer diagnostics.
    • Alejandro Castillo, technology business leader and entrepreneur with over 20 years of experience working with Fortune 100 companies and tech startups. Mr. Castillo is MIT-Certified AI for Business and holds a postgraduate degree in AI from the University of Texas, Austin.

    Agenda

    • The Present and Future of Healthcare: An introduction to healthcare trends, future predictions and the growing role of AI.
    • Introduction to AI: An overview of machine learning, deep learning and generative AI with a specific focus on healthcare applications.
    • AI in Healthcare: A session on the impact of AI on diagnostics, treatment plans and patient outcomes, covering real-world examples as well as critical issues like data privacy and cybersecurity.
    • Expert Panel Discussion: A lively discussion on the ethical and practical implications of AI in healthcare, followed by an audience Q&A session.
    • Generative AI Applications in Healthcare**: A look at how generative AI is transforming the healthcare discovery process.

    Date: October 16, 2024

    Time: 3:00 p.m. - 6:00 p.m.

    Location: Auditorio FEPADE, San Salvador

    For more information and to purchase tickets, please scan the QR code or contact: [email protected]

    About ProntoMedic

    ProntoMedic is an early-stage incubator of innovative digital healthcare solutions, strategically positioned at the crossroads of Latin American and global healthcare systems. With operational hubs in Austin, Texas, and San Salvador, El Salvador, we are dedicated to advancing the future of healthcare through generative AI and machine learning technologies. Our mission is to develop cutting-edge, culturally attuned solutions that meet the unique needs of the Latin American population, while bridging the gap between regional healthcare systems and international standards.

    About VSee Health

    VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health's system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.

    With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, and tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241009397315/en/

    Get the next $VSEE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    SEC Filings

    View All

    SEC Form 424B3 filed by VSee Health Inc.

    424B3 - VSEE HEALTH, INC. (0001864531) (Filer)

    3/5/26 6:01:08 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    3/3/26 4:05:42 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    2/19/26 5:15:22 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director O'Sullivan Colin P. was granted 40,107 shares, increasing direct ownership by 58% to 108,731 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/6/26 4:31:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Director Metzger Scott was granted 40,107 shares, increasing direct ownership by 52% to 117,356 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/6/26 4:30:33 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Director Lowdermilk Kevin was granted 40,107 shares, increasing direct ownership by 58% to 108,731 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/5/26 4:32:42 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services